TRPC4 and TRPC7 associated with lung cancer risk in 4866 case-control
Adverse effects of TRPCs variants estimated based on the pathway study
Subjects carrying “≥ 1” variant alleles had a 1.29-fold risk, compared with “0”.
Lung cancer risk increased with variant allele's number in a dose-response.